Fiverr International Ltd vs Eli Lilly And Co — how do they compare? Fiverr International Ltd trades at $8.7 (market cap $314.57M), while Eli Lilly And Co trades at $1,216 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 3433.3× Fiverr International Ltd's market cap, and Eli Lilly And Co pays a 0.57% dividend while Fiverr International Ltd pays none. Which is the better fit depends on your goals.
| FVRR | LLY | |
|---|---|---|
Market Cap | $314.57M | $1.08T |
Sector | Industrials | Health |
52-Week High | $26.67 | $1.24K |
52-Week Low | $8.75 | $639.43 |
Enterprise Value | $66.95M | $1.13T |
Dividend Yield | — | 0.57% |
Signals from Pluang's Aura AI — not financial advice
Fiverr International (FVRR) trades at $9.09, down 3.5% amid bearish technical signals and recent earnings misses. The stock shows attractive valuation metrics with P/E of 10.8 and P/S of 0.77, while revenue grew to $430.91M in 2025. However, Q2 2026 results disappointed with revenue declining 10% year-over-year as AI disruption pressures the freelance marketplace business model. Analyst sentiment remains cautious with 76% hold ratings despite a $10.70 consensus price target suggesting 18% upside potential.
Fiverr faces significant headwinds from AI competition compressing demand for lower-value freelance work, though current valuations appear discounted. The company maintains strong gross margins at 82% and positive net income, but growth sustainability concerns persist. Near-term catalysts include Q3 earnings and AI strategy execution, while risks center on market share erosion and guidance revisions. The stock trades near support levels with mixed technical indicators.
Eli Lilly (LLY) trades at $1,221.21, down 0.84% today, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The stock shows technical strength with bullish moving averages and support at $1,207, while fundamentals reveal exceptional profitability with 33.53% net margins and 48% revenue growth in Q2 2026. Recent news highlights the company's aggressive protection of its obesity drug pipeline against black market sales.
LLY presents a compelling growth story with dominant market positioning in weight-loss drugs and strong analyst support (73% buy ratings). Key risks include regulatory scrutiny and competitive pressures, but the company's raised guidance and pipeline advancements support continued upside toward the $1,380 consensus target.
Trailing returns across standard periods
Latest headlines on both assets
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.
Read more on FVRR →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →